Join our daily newsletter At The Bell to receive exclusive market insights
- BrainChip (BRN) strengthens its patent portfolio with AU 2022203607, marking its leadership in neuromorphic AI
- The patent protects event-based convolution techniques for digital input data transformed into events
- BrainChip’s patented tech enables advanced edge applications with fewer event-based neuron circuits
- BRN now holds 18 global patents and has 30 pending applications
- Shares last traded at 32.5 cents
BrainChip (BRN) has announced the registration of another patent in Australia to protect its growing portfolio of neuromorphic artificial intelligence microchip technology.
The company lodged a patent titled “Event-Based Extraction of Features In A Convolutional Spiking Neural Network” with the patent office awarding rights to the company.
BrainChip management expects this move to protect the company’s “ultra-low power neuromorphic AI IP.”
Neuromorphic AI refers to artificial intelligence technology modelled after processes in the human brain, which has been normalised in machine learning ‘neural network’ models.
BrainChip’s portfolio now comprises 18 issued patents, including 12 in the US, four in Australia, one in EP, and one in China. It also holds 30 patent applications across the globe.
The news saw BrainChip buck the overall market trend on Friday in morning trades, with the company in the green, as opposed to the ASX200 in the red.
BRN shares last traded at 32.5 cents.
